Abzena, a research organization providing development and manufacturing for biopharmaceutical companies, announced it has raised a $10 million growth capital investment from Biospring Partners, a newly launched New York firm. Biospring said the funding will allow Abzena to accelerate its growth plans. The company, owned by Welsh Carson Anderson & Stowe, has facilities in Cambridge, UK, San Diego and Philadelphia.
This is the first investment announced by Biospring Partners, a growth-stage life sciences investor founded this year by Michelle Dipp and Jennifer Lum.
As part of its investment in Abzena, Dipp will join the company’s board.
Source: Biospring Partners
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: